ReviewPharmacology research & perspectives2020

Pharmacological hypothesis: TPC2 antagonist tetrandrine as a potential therapeutic agent for COVID-19.

Paula M Heister et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.